Catalyst Pharmaceutical Partners Inc buy Bank of America Co.
Start price
09.01.25
/
50%
€23.55
Target price
09.01.26
€29.13
Performance (%)
-16.45%
End price
10.01.26
€19.68
Summary
This prediction ended on 10.01.26 with a price of €19.68. The price of Catalyst Pharmaceutical Partners Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.45%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 0.685% | 0.685% | -3.333% |
| iShares Core DAX® | -3.986% | -2.814% | 4.157% |
| iShares Nasdaq 100 | 0.345% | -0.748% | 9.471% |
| iShares Nikkei 225® | -3.853% | 4.229% | 28.358% |
| iShares S&P 500 | 0.298% | 0.379% | 6.139% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at Bank of America Co.. They now have a $30.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Bank_of_America_Co_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.95
07.03.24
07.03.24
€21.15
07.03.25
07.03.25
32.99%
08.03.25
08.03.25
